These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2086826)

  • 1. [Pathogenesis of involutional osteoporosis].
    Orimo H; Kanaki M
    Nihon Rinsho; 1990 Dec; 48(12):2726-8. PubMed ID: 2086826
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiology and risk factors of involutional osteoporosis].
    Orimo H; Kaneki M
    Nihon Rinsho; 1990 Dec; 48(12):2862-6. PubMed ID: 2086846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteoporosis. Current advances in etiopathogenesis, diagnosis and therapy. I.--Etiopathogenesis and diagnosis].
    Cotrozzi G; Relli P
    Clin Ter; 1994 Mar; 144(3):251-63. PubMed ID: 8181222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis profile].
    Dyerberg J
    Ugeskr Laeger; 1994 Sep; 156(38):5536-7. PubMed ID: 7941092
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathology behind age-related bone loss. New insight in the mechanisms of cellular and molecular biology].
    Kassem MS; Mosekilde L; Eriksen EF
    Ugeskr Laeger; 1999 Oct; 161(41):5663-6. PubMed ID: 10565234
    [No Abstract]   [Full Text] [Related]  

  • 6. [Involutional osteoporosis--pathogenesis, diagnosis, prevention and therapy].
    Kuska J; Wiecek A; Czech U
    Postepy Hig Med Dosw; 1991; 45(1-2):101-17. PubMed ID: 1923992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Osteoporosis in postmenopausal women].
    Orimo H
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):785-90. PubMed ID: 2230411
    [No Abstract]   [Full Text] [Related]  

  • 8. [Normal bone remodelling--what can go wrong in osteoporosis?].
    Midtby M; Magnus JH
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):552-7. PubMed ID: 9520583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects of bone mineral content in osteoporosis].
    Nishizawa Y; Miki T; Nakatsuka K; Hagiwara S; Iba K; Morii H
    Nihon Ronen Igakkai Zasshi; 1992 Apr; 29(4):257-61. PubMed ID: 1614003
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
    J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone matrix insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor (TGF)-beta1 levels in men and postmenopausal women with osteoporosis: lack of association with circulating growth factors and bone mineral density.
    Georgescu C; Seck T; Diel I; Minne H; Duncea I; Pfeilschifter J
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(2):281-6. PubMed ID: 15688799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Bone markers"--when can they be useful?].
    Skjøstad JB
    Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3228-9. PubMed ID: 9411863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    Riggs BL; Khosla S; Melton LJ
    J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteoporosis--pathogenesis and prophylaxis].
    Skrzypulec V; Rozmus-Warcholińska W; Walaszek A; Drosdzol A; Nowosielski K; Piela B
    Wiad Lek; 2004; 57 Suppl 1():295-300. PubMed ID: 15884261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factors and bone formation in osteoporosis: roles for IGF-I and TGF-beta.
    Marie P
    Rev Rhum Engl Ed; 1997 Jan; 64(1):44-53. PubMed ID: 9051859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Androgens and bone metabolism. Significance in osteoporosis in man and woman].
    Kasperk CH; Ziegler R
    Dtsch Med Wochenschr; 1992 Jun; 117(25):990-6. PubMed ID: 1611969
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differential osteoporosis diagnosis in the woman].
    Lippuner K; Jaeger P
    Ther Umsch; 1998 Nov; 55(11):685-95. PubMed ID: 9865145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle strength, bone mass, and age-related bone loss.
    Burr DB
    J Bone Miner Res; 1997 Oct; 12(10):1547-51. PubMed ID: 9333114
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of vitamin D and its metabolites in the pathogenesis and therapy of osteoporosis].
    Scharla SH; Ziegler R
    Dtsch Med Wochenschr; 1994 Jun; 119(23):847-51. PubMed ID: 8005057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.